{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T00:53:00Z","timestamp":1794617580464,"version":"4.9.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,11]],"date-time":"2019-11-11T00:00:00Z","timestamp":1573430400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,11,11]],"date-time":"2019-11-11T00:00:00Z","timestamp":1573430400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n              <jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>High-risk human papillomavirus (HR-HPV) testing is more sensitive than cytology for the detection of cervical cancer and its precursors. However, limited and inconsistent data are available about the efficacy of the combination of these two methods for screening cervical adenocarcinoma. This multicenter retrospective study investigated the screening results of a cohort of Chinese patients who were subsequently diagnosed with invasive cervical adenocarcinoma, with the goal of identifying the optimal cervical adenocarcinoma screening method.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We retrospectively retrieved and analyzed the data from patients with histologically confirmed primary invasive cervical adenocarcinoma from eight local pathology laboratories operated by KingMed Diagnostics, the largest independent operator of pathology laboratories in China, over a 2-year period. Only patients who underwent cytology and\/or HR-HPV testing within 6\u2009months before the adenocarcinoma diagnosis were included. HR-HPV DNA was detected using one of two HPV test kits: the Hybrid Capture 2 (HC2) assay (Qiagen, Hilden, Germany) and an HPV genotyping panel (Yaneng Bio, Shenzhen, China).<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Of the 311 patients, 136 underwent cytology alone, 106 underwent HR-HPV testing alone, and 69 underwent cytology and HR-HPV co-testing. The sensitivities of cytology alone (64.0, 95% confidence interval [CI]: 55.9\u201372.0) and HR-HPV testing alone (66.0, 95% CI: 57.0\u201375.1) were similar (<jats:italic>P<\/jats:italic>\u2009=\u20090.738). The sensitivity of cytology and HR-HPV co-testing (87.0, 95% CI: 79.0\u201394.9) was significantly higher than that of either cytology (<jats:italic>P<\/jats:italic>\u2009=\u20090.001) or HR-HPV testing alone (<jats:italic>P<\/jats:italic>\u2009=\u20090.002).<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Both cytology alone and HR-HPV testing alone showed poor screening efficiency, whereas the combination of the two clearly increased the efficiency of primary cervical adenocarcinoma screening. Thus, cytology and HR-HPV co-testing might be the most efficient cervical adenocarcinoma screening method.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12879-019-4614-y","type":"journal-article","created":{"date-parts":[[2019,11,11]],"date-time":"2019-11-11T14:03:25Z","timestamp":1573481005000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Prior cervical cytology and high-risk HPV testing results for 311 patients with invasive cervical adenocarcinoma: a multicenter retrospective study from China\u2019s largest independent operator of pathology laboratories"],"prefix":"10.1186","volume":"19","author":[{"given":"Fengxiang","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liran","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongman","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingsong","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuelian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debo","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,11]]},"reference":[{"issue":"10","key":"4614_CR1","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1089\/jwh.2011.3385","volume":"21","author":"O Adegoke","year":"2012","unstructured":"Adegoke O, Kulasingam S, Virnig B. Cervical cancer trends in the United States: a 35-year population-based analysis. J Women's Health (Larchmt). 2012;21(10):1031\u20137.","journal-title":"J Women's Health (Larchmt)"},{"issue":"4","key":"4614_CR2","first-page":"645","volume":"10","author":"A Mathew","year":"2009","unstructured":"Mathew A, George PS. Trends in incidence and mortality rates of squamous cell carcinoma and adenocarcinoma of cervix--worldwide. Asian Pac J Cancer Prev. 2009;10(4):645\u201350.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"2","key":"4614_CR3","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1002\/cam4.971","volume":"6","author":"J van der Horst","year":"2017","unstructured":"van der Horst J, Siebers AG, Bulten J, Massuger LF, de Kok IM. Increasing incidence of invasive and in situ cervical adenocarcinoma in the Netherlands during 2004-2013. Cancer Med. 2017;6(2):416\u201323.","journal-title":"Cancer Med"},{"issue":"1","key":"4614_CR4","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/sj.bjc.6690666","volume":"81","author":"R Bergstrom","year":"1999","unstructured":"Bergstrom R, Sparen P, Adami HO. Trends in cancer of the cervix uteri in Sweden following cytological screening. Br J Cancer. 1999;81(1):159\u201366.","journal-title":"Br J Cancer"},{"issue":"2","key":"4614_CR5","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1006\/gyno.2000.5826","volume":"78","author":"HO Smith","year":"2000","unstructured":"Smith HO, Tiffany MF, Qualls CR, Key CR. The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States--a 24-year population-based study. Gynecol Oncol. 2000;78(2):97\u2013105.","journal-title":"Gynecol Oncol"},{"issue":"4","key":"4614_CR6","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1097\/LGT.0000000000000408","volume":"22","author":"W Chen","year":"2018","unstructured":"Chen W, Sun H, Molijn A, Zeng L, Kang L, Jenkins D, et al. The variable characteristics of human papillomavirus in squamous cell carcinoma and adenocarcinoma of cervix in China. J Low Genit Tract Dis. 2018;22(4):355\u201361.","journal-title":"J Low Genit Tract Dis"},{"issue":"6","key":"4614_CR7","first-page":"e180618","volume":"12","author":"L Zhang","year":"2017","unstructured":"Zhang L, Xie F, Wang X, Peng D, Bi C, Jiang L, et al. Previous cervical cytology and high-risk human papillomavirus testing in a cohort of patients with invasive cervical carcinoma in Shandong Province. China Plos One. 2017;12(6):e180618.","journal-title":"China Plos One"},{"issue":"2","key":"4614_CR8","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.ygyno.2012.01.012","volume":"125","author":"V Galic","year":"2012","unstructured":"Galic V, Herzog TJ, Lewin SN, Neugut AI, Burke WM, Lu YS, et al. Prognostic significance of adenocarcinoma histology in women with cervical cancer. Gynecol Oncol. 2012;125(2):287\u201391.","journal-title":"Gynecol Oncol"},{"issue":"9895","key":"4614_CR9","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/S0140-6736(13)60022-7","volume":"382","author":"EJ Crosbie","year":"2013","unstructured":"Crosbie EJ, Einstein MH, Franceschi S, Kitchener HC. Human papillomavirus and cervical cancer. Lancet. 2013;382(9895):889\u201399.","journal-title":"Lancet."},{"issue":"2","key":"4614_CR10","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.ejogrb.2013.01.012","volume":"168","author":"ML Sammarco","year":"2013","unstructured":"Sammarco ML, Del RI, Tamburro M, Grasso GM, Ripabelli G. Type-specific persistence and associated risk factors of human papillomavirus infections in women living in Central Italy. Eur J Obstet Gynecol Reprod Biol. 2013;168(2):222\u20136.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"9916","key":"4614_CR11","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/S0140-6736(13)62218-7","volume":"383","author":"G Ronco","year":"2014","unstructured":"Ronco G, Dillner J, Elfstrom KM, Tunesi S, Snijders PJ, Arbyn M, et al. Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials. Lancet. 2014;383(9916):524\u201332.","journal-title":"Lancet"},{"issue":"1","key":"4614_CR12","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/S1470-2045(11)70296-0","volume":"13","author":"DC Rijkaart","year":"2012","unstructured":"Rijkaart DC, Berkhof J, Rozendaal L, van Kemenade FJ, Bulkmans NW, Heideman DA, et al. Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial. Lancet Oncol. 2012;13(1):78\u201388.","journal-title":"Lancet Oncol"},{"issue":"3","key":"4614_CR13","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/S1470-2045(09)70360-2","volume":"11","author":"G Ronco","year":"2010","unstructured":"Ronco G, Giorgi-Rossi P, Carozzi F, Confortini M, Dalla PP, Del MA, et al. Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial. Lancet Oncol. 2010;11(3):249\u201357.","journal-title":"Lancet Oncol."},{"issue":"12","key":"4614_CR14","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1016\/S1470-2045(10)70256-4","volume":"11","author":"FH Zhao","year":"2010","unstructured":"Zhao FH, Lin MJ, Chen F, Hu SY, Zhang R, Belinson JL, et al. Performance of high-risk human papillomavirus DNA testing as a primary screen for cervical cancer: a pooled analysis of individual patient data from 17 population-based studies from China. Lancet Oncol. 2010;11(12):1160\u201371.","journal-title":"Lancet Oncol."},{"issue":"7","key":"4614_CR15","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/S1470-2045(11)70145-0","volume":"12","author":"HA Katki","year":"2011","unstructured":"Katki HA, Kinney WK, Fetterman B, Lorey T, Poitras NE, Cheung L, et al. Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice. Lancet Oncol. 2011;12(7):663\u201372.","journal-title":"Lancet Oncol"},{"issue":"2","key":"4614_CR16","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.canep.2009.12.010","volume":"34","author":"G Ripabelli","year":"2010","unstructured":"Ripabelli G, Grasso GM, Del RI, Tamburro M, Sammarco ML. Prevalence and genotype identification of human papillomavirus in women undergoing voluntary cervical cancer screening in Molise, Central Italy. Cancer Epidemiol. 2010;34(2):162\u20137.","journal-title":"Cancer Epidemiol"},{"issue":"2","key":"4614_CR17","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.ygyno.2014.12.022","volume":"136","author":"WK Huh","year":"2015","unstructured":"Huh WK, Ault KA, Chelmow D, Davey DD, Goulart RA, Garcia FA, et al. Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance. Gynecol Oncol. 2015;136(2):178\u201382.","journal-title":"Gynecol Oncol"},{"issue":"4","key":"4614_CR18","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1097\/AOG.0b013e3182883a34","volume":"121","author":"LS Massad","year":"2013","unstructured":"Massad LS, Einstein MH, Huh WK, Katki HA, Kinney WK, Schiffman M, et al. 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. Obstet Gynecol. 2013;121(4):829\u201346.","journal-title":"Obstet Gynecol"},{"issue":"11","key":"4614_CR19","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/S1470-2045(10)70230-8","volume":"11","author":"S de Sanjose","year":"2010","unstructured":"de Sanjose S, Quint WG, Alemany L, Geraets DT, Klaustermeier JE, Lloveras B, et al. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol. 2010;11(11):1048\u201356.","journal-title":"Lancet Oncol"},{"issue":"4","key":"4614_CR20","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1002\/ijc.25396","volume":"128","author":"N Li","year":"2011","unstructured":"Li N, Franceschi S, Howell-Jones R, Snijders PJ, Clifford GM. Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: variation by geographical region, histological type and year of publication. Int J Cancer. 2011;128(4):927\u201335.","journal-title":"Int J Cancer"},{"issue":"12","key":"4614_CR21","doi-asserted-by":"publisher","first-page":"2687","DOI":"10.1002\/ijc.30401","volume":"139","author":"W Chen","year":"2016","unstructured":"Chen W, Molijn A, Enqi W, Zhang X, Jenkins D, Yu X, et al. The variable clinicopathological categories and role of human papillomavirus in cervical adenocarcinoma: a hospital based nation-wide multi-center retrospective study across China. Int J Cancer. 2016;139(12):2687\u201397.","journal-title":"Int J Cancer"},{"issue":"12","key":"4614_CR22","doi-asserted-by":"publisher","first-page":"2858","DOI":"10.1002\/ijc.29651","volume":"137","author":"K Holl","year":"2015","unstructured":"Holl K, Nowakowski AM, Powell N, McCluggage WG, Pirog EC, Collas DSS, et al. Human papillomavirus prevalence and type-distribution in cervical glandular neoplasias: results from a European multinational epidemiological study. Int J Cancer. 2015;137(12):2858\u201368.","journal-title":"Int J Cancer"},{"issue":"12","key":"4614_CR23","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1038\/modpathol.2014.55","volume":"27","author":"EC Pirog","year":"2014","unstructured":"Pirog EC, Lloveras B, Molijn A, Tous S, Guimera N, Alejo M, et al. HPV prevalence and genotypes in different histological subtypes of cervical adenocarcinoma, a worldwide analysis of 760 cases. Mod Pathol. 2014;27(12):1559\u201367.","journal-title":"Mod Pathol"},{"issue":"7","key":"4614_CR24","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1002\/cncy.21557","volume":"123","author":"B Zheng","year":"2015","unstructured":"Zheng B, Li Z, Griffith CC, Yan S, Chen C, Ding X, et al. Prior high-risk HPV testing and pap test results for 427 invasive cervical cancers in China's largest CAP-certified laboratory. Cancer Cytopathol. 2015;123(7):428\u201334.","journal-title":"Cancer Cytopathol"},{"issue":"7","key":"4614_CR25","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1002\/cncy.21545","volume":"123","author":"X Tao","year":"2015","unstructured":"Tao X, Griffith CC, Zhou X, Wang Z, Yan Y, Li Z, et al. History of high-risk HPV and pap test results in a large cohort of patients with invasive cervical carcinoma: experience from the largest women's hospital in China. Cancer Cytopathol. 2015;123(7):421\u20137.","journal-title":"Cancer Cytopathol."},{"issue":"5","key":"4614_CR26","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1002\/cncy.21544","volume":"123","author":"AJ Blatt","year":"2015","unstructured":"Blatt AJ, Kennedy R, Luff RD, Austin RM, Rabin DS. Comparison of cervical cancer screening results among 256,648 women in multiple clinical practices. Cancer Cytopathol. 2015;123(5):282\u20138.","journal-title":"Cancer Cytopathol"},{"issue":"1","key":"4614_CR27","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/j.1365-2303.2011.00955.x","volume":"23","author":"RM Austin","year":"2012","unstructured":"Austin RM, Zhao C. Type 1 and type 2 cervical carcinomas: some cervical cancers are more difficult to prevent with screening. Cytopathology. 2012;23(1):6\u201312.","journal-title":"Cytopathology."},{"issue":"4","key":"4614_CR28","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/0002-9378(83)90814-1","volume":"146","author":"RW Bain","year":"1983","unstructured":"Bain RW, Crocker DW. Rapid onset of cervical cancer in an upper socioeconomic group. Am J Obstet Gynecol. 1983;146(4):366\u201371.","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"4614_CR29","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1093\/ajcp\/aqy022","volume":"150","author":"W Jiang","year":"2018","unstructured":"Jiang W, Marshall AR, Li L, Yang K, Zhao C. Extended human papillomavirus genotype distribution and cervical cytology results in a large cohort of chinese women with invasive cervical cancers and high-grade squamous intraepithelial lesions. Am J Clin Pathol. 2018;150(1):43\u201350.","journal-title":"Am J Clin Pathol"},{"key":"4614_CR30","first-page":"84","volume":"5","author":"F Xie","year":"2018","unstructured":"Xie F, Li Z, Zhang L, Zhang H, Qi D, Zhao D, et al. Systemic cervical cytology training and quality control programs can improve the interpretation of Papanicolaou tests. J Am Soc Cytopathol. 2018;5:84\u20139.","journal-title":"J Am Soc Cytopathol"},{"issue":"1","key":"4614_CR31","first-page":"e210311","volume":"14","author":"L Jiang","year":"2019","unstructured":"Jiang L, Tian X, Peng D, Zhang L, Xie F, Bi C, et al. HPV prevalence and genotype distribution among women in Shandong Province, China: analysis of 94,489 HPV genotyping results from Shandong's largest independent pathology laboratory. PLoS One. 2019;14(1):e210311.","journal-title":"PLoS One"},{"issue":"6","key":"4614_CR32","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1111\/j.1479-828X.2007.00788.x","volume":"47","author":"SC Pak","year":"2007","unstructured":"Pak SC, Martens M, Bekkers R, Crandon AJ, Land R, Nicklin JL, et al. Pap smear screening history of women with squamous cell carcinoma and adenocarcinoma of the cervix. Aust N Z J Obstet Gynaecol. 2007;47(6):504\u20137.","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"1","key":"4614_CR33","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/1097-0142(20010225)93:1<8::AID-CNCR9001>3.0.CO;2-K","volume":"93","author":"JF Krane","year":"2001","unstructured":"Krane JF, Granter SR, Trask CE, Hogan CL, Lee KR. Papanicolaou smear sensitivity for the detection of adenocarcinoma of the cervix: a study of 49 cases. Cancer. 2001;93(1):8\u201315.","journal-title":"Cancer."},{"issue":"1","key":"4614_CR34","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1093\/ajcp\/107.1.30","volume":"107","author":"KR Lee","year":"1997","unstructured":"Lee KR, Minter LJ, Granter SR. Papanicolaou smear sensitivity for adenocarcinoma in situ of the cervix. A study of 34 cases. Am J Clin Pathol. 1997;107(1):30\u20135.","journal-title":"Am J Clin Pathol"},{"issue":"4","key":"4614_CR35","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1002\/dc.10278","volume":"28","author":"AT Moriarty","year":"2003","unstructured":"Moriarty AT, Wilbur D. Those gland problems in cervical cytology: faith or fact? Observations from the Bethesda 2001 terminology conference. Diagn Cytopathol. 2003;28(4):171\u20134.","journal-title":"Diagn Cytopathol"},{"issue":"6","key":"4614_CR36","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1002\/cncr.11826","volume":"99","author":"A Simsir","year":"2003","unstructured":"Simsir A, Hwang S, Cangiarella J, Elgert P, Levine P, Sheffield MV, et al. Glandular cell atypia on Papanicolaou smears: interobserver variability in the diagnosis and prediction of cell of origin. Cancer. 2003;99(6):323\u201330.","journal-title":"Cancer."},{"issue":"12","key":"4614_CR37","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.5858\/arpa.2016-0356-RA","volume":"141","author":"EC Pirog","year":"2017","unstructured":"Pirog EC. Cervical adenocarcinoma: diagnosis of human papillomavirus-positive and human papillomavirus-negative tumors. Arch Pathol Lab Med. 2017;141(12):1653\u201367.","journal-title":"Arch Pathol Lab Med"},{"issue":"2","key":"4614_CR38","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1002\/ijc.29722","volume":"138","author":"A Molijn","year":"2016","unstructured":"Molijn A, Jenkins D, Chen W, Zhang X, Pirog E, Enqi W, et al. The complex relationship between human papillomavirus and cervical adenocarcinoma. Int J Cancer. 2016;138(2):409\u201316.","journal-title":"Int J Cancer"},{"issue":"5","key":"4614_CR39","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1093\/ajcp\/aqx027","volume":"147","author":"X Tao","year":"2017","unstructured":"Tao X, Zheng B, Yin F, Zeng Z, Li Z, Griffith CC, et al. Polymerase chain reaction human papillomavirus (HPV) detection and HPV genotyping in invasive cervical cancers with prior negative HC2 test results. Am J Clin Pathol. 2017;147(5):477\u201383.","journal-title":"Am J Clin Pathol"},{"issue":"12","key":"4614_CR40","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.5858\/arpa.2011-0609-OA","volume":"136","author":"Z Li","year":"2012","unstructured":"Li Z, Austin RM, Guo M, Zhao C. Screening test results associated with cancer diagnoses in 287 women with cervical squamous cell carcinoma. Arch Pathol Lab Med. 2012;136(12):1533\u201340.","journal-title":"Arch Pathol Lab Med."},{"key":"4614_CR41","doi-asserted-by":"crossref","unstructured":"Integrated genomic and molecular characterization of cervical cancer. Nature. 2017;543(7645):378\u2013384.","DOI":"10.1038\/nature21386"},{"issue":"2","key":"4614_CR42","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.ygyno.2014.03.008","volume":"133","author":"QJ Pan","year":"2014","unstructured":"Pan QJ, Hu SY, Guo HQ, Zhang WH, Zhang X, Chen W, et al. Liquid-based cytology and human papillomavirus testing: a pooled analysis using the data from 13 population-based cervical cancer screening studies from China. Gynecol Oncol. 2014;133(2):172\u20139.","journal-title":"Gynecol Oncol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-019-4614-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-019-4614-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-019-4614-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,10]],"date-time":"2020-11-10T00:14:17Z","timestamp":1604967257000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-019-4614-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,11]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["4614"],"URL":"https:\/\/doi.org\/10.1186\/s12879-019-4614-y","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,11]]},"assertion":[{"value":"7 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the ethics review board of KingMed Diagnostics. The ethics review board waived the need of patients\u2019 consent due to anonymous analyses of the data. The management and publication of patients\u2019 information in this study was strictly in accordance with the Declaration of Helsinki, including the confidentiality and anonymity.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}],"article-number":"962"}}